Tag: ATNX News

Business

The European Commission Has Granted Athenex Inc (NASDAQ: ATNX) Approval for its Klisyri Drug

Athenex Inc (NASDAQ: ATNX)┬áis a global biopharma firm that concentrates on the commercialization, discovery, and development of novel therapeutic treatments for cancer and other related conditions. It recently announced that Almirall, S.A., its partner, has received European Commission approval to market its Klisyri drug. Klisyri is designed to treat actinic […]